Skip to content

One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™

A One-Year, Multicenter, Observational, Follow-up Safety Study in Subjects Previously Implanted With VC-01™ Combination Product

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02939118
Enrollment
51
Registered
2016-10-19
Start date
2016-11-07
Completion date
2024-02-08
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus

Brief summary

The purpose of this trial is to evaluate the long-term safety in subjects previously implanted with VC-01™ combination product.

Interventions

None listed

Sponsors

ViaCyte
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Previous implantation of VC-01™ combination product with subsequent explantation of all VC-01 units.

Exclusion criteria

* There are no

Design outcomes

Primary

MeasureTime frame
Incidence of adverse events reported during the study.12 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026